Dishman Carbogen Amcis Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
November 11, 2022 at 05:18 am EST
Share
Dishman Carbogen Amcis Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 6,139.6 million compared to INR 4,589 million a year ago. Revenue was INR 6,228.1 million compared to INR 4,685 million a year ago. Net loss was INR 100.5 million compared to net income of INR 111.9 million a year ago. Basic loss per share from continuing operations was INR 0.64 compared to basic earnings per share from continuing operations of INR 0.71 a year ago. Diluted loss per share from continuing operations was INR 0.64 compared to diluted earnings per share from continuing operations of INR 0.71 a year ago.
For the six months, sales was INR 11,545.7 million compared to INR 10,096.3 million a year ago. Revenue was INR 11,690.9 million compared to INR 10,296.4 million a year ago. Net loss was INR 60.4 million compared to net income of INR 272.1 million a year ago. Basic loss per share from continuing operations was INR 0.39 compared to basic earnings per share from continuing operations of INR 1.74 a year ago. Diluted loss per share from continuing operations was INR 0.39 compared to diluted earnings per share from continuing operations of INR 1.74 a year ago.
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Companyâs segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.
DISHMAN CARBOGEN AMCIS LIMITED 
